Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharmaxis, a specialty pharmaceutical company, has appointed Praxis Pharmaceutical France as its French marketer and distributer for the asthma diagnostic tool, Aridol.
Subscribe to our email newsletter
Praxis will complete the reimbursement application for Aridol in France and thereafter market the product to hospital specialists.
Alan Robertson, CEO of Pharmaxis, said: “We are delighted to announce this agreement and are looking forward to working with Praxis on developing the French market for Aridol.
“Aridol is a precisely engineered test that we believe will be an improvement on current practice. Aridol improves the identification of bronchial hyperresponsiveness which is one of the hallmarks of asthma.”